COMMUNIQUÉS West-GlobeNewswire

-
Medtronic Launches ENCHANT Study to Evaluate ChEVAR Parallel Graft Technique with the Endurant(TM) II/IIs Stent Graft System
24/01/2018 -
Fibrocell to Present at Phacilitate Cell and Gene Therapy World 2018
24/01/2018 -
Treatment Commences in Second Patient Cohort in Cynata’s World First Clinical Trial
24/01/2018 -
Sorrento Therapeutics CAR-T Manufacturing Capacity Expanded With Opening of East Coast GMP Site in Addition to Primary West Coast Facility
24/01/2018 -
CASMED Submits FORE-SIGHT® OEM Module 510(k) to FDA
24/01/2018 -
VitalHub Subsidiary B Sharp Technologies Signs Strategic Deal to Provide More Children Access to Critical Mental Health Support in Canada
24/01/2018 -
Helius Medical Technologies and US Army Research Laboratory Launch Additional PoNS® Research
24/01/2018 -
Immunovaccine Named to 2018 OTCQX Best 50
24/01/2018 -
IntelGenx Initiates Phase 2A Montelukast Versafilm™ Clinical Trial in Alzheimer’s Patients
24/01/2018 -
Intellipharmaceutics Provides Operational Update
24/01/2018 -
Santhera Anticipates Receiving a Negative CHMP Opinion on Appeal for Marketing Authorization Application for Raxone® in Duchenne Muscular Dystrophy
24/01/2018 -
Exalenz Bioscience Announces Positive Clinical Trial Results For the Diagnosis of Clinically Significant Portal Hypertension in NASH Patients
24/01/2018 -
Abstract Outlining Pre-Hospital Stroke Study with Diffusion Pharmaceuticals’ TSC To Be Presented at the International Stroke Conference
24/01/2018 -
BioCorRx Announces Collaboration with the One Day at a Time Program in Philadelphia
24/01/2018 -
TG Therapeutics, Inc. Announces Data Presentation at the Upcoming Third Annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2018
24/01/2018 -
FDA has approved Faron's Traumakine® IND
24/01/2018 -
miRagen Therapeutics to Present New MRG-106 Phase 1 Clinical Trial Data at the T-Cell Lymphoma Forum
24/01/2018 -
pSivida Corp. Announces Second Quarter Fiscal Year 2018 Financial Results Release Date and Conference Call Information
24/01/2018 -
TRIO Announces Participation in the Avoca Diligent™ Prequalification Platform
24/01/2018
Pages